PBC Biomed are delighted to announce the launch of our client Mochida Pharmaceutical Co., Ltd. innovative new nerve repair product – ReFeel® Nerve Repair Solution.
ReFeel® is #biocompatible in nature and uses a proprietary alginate and PGA formula to create a bridge for #nerve #regeneration. The freeze-dried alginate sheet suppresses the migration and proliferation of cells that make up granulation tissue; providing a protected environment which facilitates the natural healing process of the nerve.
The PBC Biomed Design & Development, Clinical, Regulatory and Commercial teams have been working alongside Mochida Pharmaceutical Co., Ltd. for the last four years; preparing this technology for commercial release.
ReFeel® will officially be launched at the American Society for Surgery of the Hand (ASSH) conference in Minneapolis this week. Visit booth #210 for more information on this exciting new technology!
Caution: Prescription use only. Federal law (USA) restricts this device to sale by or on the order of a physician.
#acceleraratingmedicalinnovation #ASSH24
Launch of ReFeel® Nerve Repair Solution at ASSH 2024
Search News Items
Categories
- Awards (11)
- Biomaterials (24)
- Biovet (13)
- Bone Adhesive (20)
- Bone Disease Solution (4)
- Bone Healing (14)
- Certification (1)
- Client (2)
- Collaboration (30)
- Conferences (24)
- Contract Manufacturing (3)
- Day One Trauma Charity (4)
- Development (21)
- Events (65)
- Government Funding (3)
- Lectures (7)
- Medical Devices (9)
- Medical Implants (6)
- Memphis Office (8)
- New Hire (11)
- On TV/Radio (2)
- Partnership (6)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (12)
- Regenerative Medicine (15)
- Relationship-building (18)
- Research (18)
- Sports & Social (3)
- Sports Partners (9)
- Student Placements (3)
- Uncategorized (6)
- Upcoming Events (6)
- US Office (6)